Articles tagged "Liver transplantation"

2019 American Transplant Congress
Evaluation of Liver Transplantation among Advanced Age Recipients in a Large Multicenter U.S. Cohort
A. Goel¹, A. Kwong², D. Devuni³, C. Wang², J. Boike⁴, J. Jo⁴, L. VanWagner⁴, M. Serper⁵, L. Jones⁵, R. Sharma⁶, E. Verna⁶, J. Shor³, M. German⁷, A. Hristov⁷, A. Lee⁷, E. Spengler⁷, A. Koteish⁸, G. Sehmbey⁹, A. Seetharam⁹, N. John¹, Y. Patel¹⁰, M. Kappus¹⁰, T. Couri¹¹, R. Salgia¹², Q. Nhu¹³, C. Frenette¹³, J. Lai²
¹Stanford University, Palo Alto, CA, ²University of California, San Francisco, CA, ³University of Massachusetts, Worcester, MA, ⁴Northwestern, Chicago, IL, ⁵University of Pennsylvania, Philadelphia, PA, ⁶Columbia University, New York, NY, ⁷University of Wisconsin, Madison, WI, ⁸Florida Hospital, Orlando, FL, ⁹University of Arizona, Phoenix, AZ, ¹⁰Duke University, Durham, NC, ¹¹University of Chicago, Chicago, IL, ¹²Henry Ford Hospital, Detroid, MI, ¹³Scripps, San Diego, CA
*Purpose: The proportion of adults ≥70 years (y) listed for liver transplant (LT) in the U.S. is rising. Outcomes in this growing population are limited…
2019 American Transplant Congress
Sequestration of PLIN2 Regulates High-Fat Diet Induced Metabolic Syndrome and Nonalcoholic Fatty Liver Disease in a Mouse Model of Ischemia Reperfusion Injury
K. Loh¹, X. Liu¹, L. Belyayev¹, C. Albanese², W. Cui¹, T. M. Fishbein¹, K. M. Khan¹, A. Kroemer¹
¹Transplant, MedStar Georgetown Transplant Institute, Washington, DC, ²Oncology, Georgetown University, Washington, DC
*Purpose: This study aimed to define characteristics and mechanisms leading to nonalcoholic fatty liver disease and metabolic syndrome in a fatty liver mouse model that…
2019 American Transplant Congress
Transplant Provider Adherence to Cardiovascular Disease Primary Prevention Guidelines in Liver Transplant Recipients
M. Kosirog¹, P. T. Campbell¹, S. Montag², S. Connolly¹, A. Daud³, A. Das¹, S. Pine¹, D. Finn³, J. Levitsky¹, J. L. Holl⁴, D. M. Lloyd-Jones⁵, L. B. VanWagner⁶
¹Division of GI and Hepatology, Department of Medicine, Northwestern Medicine, Chicago, IL, ²Department of Preventative Medicine, Northwestern Medicine, Chicago, IL, ³Center for Healthcare Studies, Northwestern Medicine, Chicago, IL, ⁴Department of Pediatrics and Center for Healthcare Studies, Northwestern Medicine, Chicago, IL, ⁵Department of Preventive Medicine and Division of Cardiology, Department of Medicine, Northwestern Medicine, Chicago, IL, ⁶Division of GI and Hepatology, Department of Medicine and Department of Preventive Medicine, Northwestern Medicine, Chicago, IL
*Purpose: Blood pressure (BP) control, aspirin, and statin use are modifiable risk factors for primary prevention of atherosclerotic cardiovascular disease (ASCVD), stroke, and heart failure…
2019 American Transplant Congress
Clinical Outcomes of Living versus Deceased Donor Liver Transplantation for Primary Sclerosing Cholangitis: A Multicenter 15 Year Experience
O. Y. Mousa¹, K. D. Watt¹, J. K. Heimbach², A. P. Keaveny³, J. E. Eaton¹, D. M. Harnois³, B. Taner³, E. J. Carey⁴, A. A. Moss⁴, C. B. Rosen⁵, T. Taner⁵
¹Department of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN, ²Department of Surgery, Mayo Clinic, Rochester, MN, ³Department of Transplant, Mayo Clinic, Jacksonville, FL, ⁴Department of Transplant, Mayo Clinic, Scottsdale, AZ, ⁵Department of Transplant, Mayo Clinic, Rochester, MN
*Purpose: MELD-based allocation is known to reduce access to deceased donor liver transplantation (DDLT) for patients with primary sclerosing cholangitis (PSC). Living donor liver transplantation(LDLT)…
2019 American Transplant Congress
Microsteatosis in Livers from Donation after Circulatory Death (DCD) Donors is Associated with Inferior Graft and Patient Survival Following Liver Transplantation (LTX)
N. Bath, G. Leverson, D. Foley
University of Wisconsin, Madison, WI
*Purpose: The current theory is that severe macrosteatosis (MaS) (>50%) in livers recovered from donation after brain death (DBD) donors leads to increased rates of…
2019 American Transplant Congress
Development and Implementation of a Pediatric Transplant Consortium
K. Soltys¹, S. K. Rassmussen², J. Squires³, R. Sindhi¹, S. Pelletier², K. Brayman², M. Angelis⁴, T. Chin⁴, R. Teaster², J. Oberholzer², R. Gonzalez-Peralta⁵, B. Friedman⁴, D. Hupp⁶, M. Mendoza⁷, P. A. Eicker⁶, J. Middleton⁷, G. Mazariegos¹
¹Transplant Surgery, Childrens Hospital of Pittsburgh of UPMC, Pittsburgh, PA, ²Charles O. Strickler Transplant Center, University of Virginia, Charlottesville, VA, ³Hepatology, Childrens Hospital of Pittsburgh of UPMC, Pittsburgh, PA, ⁴AdventHealth Transplant Institute, Florida Hospital, Orlando, FL, ⁵AdventHealth for Children, Florida Hospital, Orlando, FL, ⁶Nursing, Childrens Hospital of Pittsburgh of UPMC, Pittsburgh, PA, ⁷Hepatology, University of Virginia, Charlottesville, VA
*Purpose: Access to pediatric liver transplant expertise varies nationally and variability in practice leads to potential suboptimal organ utilization and outcomes. A multi-institutional collaborative was…
2019 American Transplant Congress
Predicting Post Liver Transplant 30-Day Readmission Using Deep Neural Network Model
S. K. Niazi¹, H. O. Park², R. E. Carter³, A. Keaveny⁴, T. Schneekloth⁵, A. Spaulding⁶, D. Harnois⁴, P. F. Moreno-Franco⁷, E. Vargas⁶, T. Rummans¹, C. Taner⁷
¹Psychiatry & Psychology, Mayo Clinic, Jacksonville, FL, ²Enterprise Analytics, Mayo Clinic, Rochester, MN, ³Health Sciences Research, Mayo Clinic, Jacksonville, FL, ⁴GI & Hepatology, Mayo Clinic, Jacksonville, FL, ⁵Psychiatry & Psychology, Mayo Clinic, Rochester, MN, ⁶Health Services Research, Mayo Clinic, Jacksonville, FL, ⁷Transplantation, Mayo Clinic, Jacksonville, FL
*Purpose: Liver transplantation (LT) is a complex, expensive process and requires multidisciplinary care. A significant portion of the estimated $735,000 LT cost can be attributed…
2019 American Transplant Congress
Donor Lymphocyte Chimerism and Homozygosity Are Critical Indicators for Timely and Accurate Diagnosis of Acute Graft vs. Host Disease after Liver Transplantation
A. Zhang, B. Eghtesad
Cleveland Clinic Foundation, Cleveland, OH
*Purpose: The mortality of Acute Graft vs. Host Disease (aGvHD) after Liver Transplantation (LT) can be greater than 85% due to delays in diagnosis and…
2019 American Transplant Congress
Evaluating Hepatitis C Treatment after Solid Organ Transplantation
A. J. Burgos¹, R. Yau¹, C. Tunwar², J. A. Goss³, S. Khaderi³, N. L. Sussman⁴
¹Pharmacy, CHI St. Luke's Health-Baylor St. Luke's Medical Center, Houston, TX, ²CHI St. Luke's Health-Baylor St. Luke's Medical Center, Houston, TX, ³Division of Abdominal Transplantation, Baylor College of Medicine, Houston, TX, ⁴Abdominal Transplant & Liver Disease, Baylor College of Medicine, Houston, TX
*Purpose: There is limited data on the use of direct acting antivirals for hepatitis C virus (HCV) in the solid organ transplant (SOT) population. The…
2019 American Transplant Congress
Impact of Previous Hepatic Resection on the Outcome of Liver Transplantation: A Case-Control Analysis
M. Serenari, M. Paterno, A. D. Pinna, M. Ravaioli, E. Prosperi, M. Del Gaudio, C. Zanfi, V. Bertuzzo, G. Frascaroli, M. Cescon
University of Bologna, Bologna, Italy
*Purpose: The aim of this study was to investigate the impact of HR on the outcome of LT.*Methods: Data of patients treated by LT between…